Provision of Antioxidant Therapy in Hemodialysis (PATH) Study

NCT00237718 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

385

Enrollment

OTHER

Sponsor class

Conditions

End-stage Renal Disease

Interventions

DRUG: Alpha, gamma, beta, and delta (mixed) tocopherols
DRUG: Alpha lipoic acid
DRUG: Placebo
DRUG: Placebo

Sponsor

Vanderbilt University

Collaborators

[object Object]